Risk Factors ID ’ d for Severe COVID - 19 With Sickle Cell Disease
Hydroxyurea use does not impact development of serious COVID - 19 or need for hospitalization in children or adults
Source: The Doctors Lounge - Oncology - Category: Cancer & Oncology Tags: Cardiology, Family Medicine, Infections, Internal Medicine, Critical Care, Emergency Medicine, Nephrology, Oncology, Pediatrics, Pulmonology, Journal, Source Type: news
More News: Cancer & Oncology | Cardiology | Child Development | Children | COVID-19 | Emergency Medicine | Heart | Internal Medicine | Pediatrics | Sickle Cell Anemia | Urology & Nephrology